• Home
  • Search Results
  • The transpedicular approach as an alternative route for intervertebral disc regeneration.

The transpedicular approach as an alternative route for intervertebral disc regeneration.

Spine (2013-01-18)
Gianluca Vadalà, Fabrizio Russo, Girish Pattappa, Damiano Schiuma, Marianna Peroglio, Lorin M Benneker, Sibylle Grad, Mauro Alini, Vincenzo Denaro
ABSTRACT

Descriptive anatomical study on ovine and human cadaveric lumbar spinal segments. To describe the alternative transpedicular approach to deliver therapeutic agents into intervertebral disc (IVD). The present delivery approach of therapeutic agents (growth factors/cells/hydrogels) within the IVD is through injection, via the annulus fibrosus (AF). However, it has recently been demonstrated that small needle puncture of the AF leads to further degeneration and disc herniation. In addition, the injected material has a high chance to be extruded through the AF injury. Lumbar ovine and human spinal segments were used. Under fluoroscopy, a 2-mm Kirschner wire was introduced in the caudal vertebra through the pedicle and the inferior endplate to the nucleus pulposus. Gross anatomy analysis and high-resolution peripheral quantitative computed tomography (HR-pQCT) were performed to assess the right position of the wire in pedicles. Discography and nucleotomy were performed using a 14G cannula insertion or a 2-mm arthroscopic shaver blade, respectively. Nucleoplasty was also performed with agarose gel/contrast agent and imaged with HR-pQCT. Gross anatomy, fluoroscopy, and HR-pQCT images showed that the nucleus pulposus could be approached through the endplate via the pedicle without affecting the spinal canal and the neural foramina. The contrast agent was delivered into the IVD and nucleus pulposus was removed from the disc and filled with agarose gel. This study describes how a transpedicular approach can be used as an alternative route to deliver therapeutic agents to the disc without disruption of the AF showing the potential use of this technique in preclinical research and highlighting its clinical relevance for IVD regeneration.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Agarose, BioReagent, for molecular biology, low EEO
Sigma-Aldrich
Agarose, Type I, low EEO
Sigma-Aldrich
Agarose, for molecular biology
Sigma-Aldrich
Sepharose® 4B, 45-165 μm bead diameter
Sigma-Aldrich
Agarose, Low EEO
Sigma-Aldrich
Agarose, Ultra-low Gelling Temperature, molecular biology grade
Sigma-Aldrich
Agarose, Ultra-low Gelling Temperature
Sigma-Aldrich
Agarose, Medium EEO, for molecular biology
Sigma-Aldrich
Agarose, Type I-A, low EEO
Sigma-Aldrich
Agarose, High Gelling Temperature
Sigma-Aldrich
Agarose, For pulsed field electrophoresis running gel
Sigma-Aldrich
Sepharose® 6B, 6% Beaded Agarose, 45-165 μm (wet), fractionation range 10,000-1,000,000 Da (dextrans)
Sigma-Aldrich
Agarose, Type II-A, Medium EEO
Sigma-Aldrich
Agarose, Wide range, for molecular biology
Sigma-Aldrich
Agarose, Low EEO, for Immunoelectrophoresis
Sigma-Aldrich
Agarose, High EEO, for molecular biology
Sigma-Aldrich
Agarose, High EEO
Sigma-Aldrich
Agarose, BioReagent, for molecular biology, Wide range/Standard 3:1
Sigma-Aldrich
Agarose, Type IV, Special High EEO
Sigma-Aldrich
Agarose, Special High EEO